The treatment which has been approved for use on the NHS from today has been hailed as ‘one of the most hopeful advances in decades for people with bladder cancer.’

Around 1,250 patients with bladder cancer in England a year could be offered the therapy, which significantly boosts survival and remission rates.

Read more – NHSE (21/8/25)